Custom-mixed hormone therapies misleading menopausal women to think personalised products are necessary, experts say

Therapies made by a compounding pharmacist are not subject to the same dosing, quality or safety standards as MHT which is TGA-approved. Photograph: BSIP/Universal Images/Getty Images

Prof Susan Davis was shocked to see her name on the website of an Australian telehealth menopause clinic offering a product she believes “is frankly reprehensible” and “misleading women”.

Davis, the director of Monash University’s Women’s Health Research Program, was concerned that the unauthorised use of her name and accompanying quotes suggested she backed the custom-made menopause hormone therapy (MHT) being sold.